vi AZ, Lane MA,
Prokop LJ, et al. A systematic review of treatment of intermittent
claudication in the lower extremities. J Vasc Surg 2015;61:54S-73S.
3. Gloviczki P, Comerota AJ, Dalsing MC, Eklof BG, Gillespie DL,
Gloviczki ML, et al. The care of patients with varicose veins and
associated chronic venous diseases: clinical practice guidelines of the
Society for Vascular Surgery and the American Venous Forum. J Vasc
Surg 2011;53(5 Suppl):2S-48S.
4. Elliott BM. Society for Vascular Surgery. Conï¬‚ict of interest and the
Society for Vascular Surgery. J Vasc Surg 2011;54(3 Suppl):3-11S.
5. Fowkes FG, Rudan D, Rudan I, Aboyans V, Denenberg JO,
McDermott MM, et al. Comparison of global estimates of prevalence
and risk factors for peripheral artery disease in 2000 and 2010: a
systematic review and analysis. Lancet 2013;382:1329-40.
6. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR,
McCann TJ, et al. Mortality over a period of 10 years in patients with
peripheral arterial disease. N Engl J Med 1992;326:381-6.
7. Hirsch AT, Hartman L, Town RJ, Virnig BA. National health care
costs of peripheral arterial disease in the Medicare population. Vasc
Med 2008;13:209-15.
8. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral
arterial disease in the United States: results from the National Health

and Nutrition Examination Survey, 1999-2000. Circulation
2004;110:738-43.
9. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA